Related references
Note: Only part of the references are listed.Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring
Marta Crespo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
Interferon-γ Release Assay for Accurate Detection of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Response
Kanagavel Murugesan et al.
CLINICAL INFECTIOUS DISEASES (2021)
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
Linda Petrone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Reinfection With SARS-CoV-2: Implications for Vaccines
Jeffrey Cohen et al.
CLINICAL INFECTIOUS DISEASES (2021)
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
Alexandra Schafer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens
Atul Garg et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Correlates of protection against SARS-CoV-2 in rhesus macaques
Katherine McMahan et al.
NATURE (2021)
T cell response to SARS-CoV-2 infection in humans: A systematic review
Madhumita Shrotri et al.
PLOS ONE (2021)
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
Kathryn E. Stephenson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
Anil Gupta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Rishi R. Goel et al.
SCIENCE (2021)
Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents
Jens T. Van Praet et al.
CLINICAL INFECTIOUS DISEASES (2021)
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
Alessandra Aiello et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay
Gustavo Echeverria et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach
Alessandra D'Abramo et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naive CD8 T cells of unexposed individuals
Isaac Quiros-Fernandez et al.
EBIOMEDICINE (2021)
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay
Isabel Brand et al.
FRONTIERS IN IMMUNOLOGY (2021)
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
Delia Goletti et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance
Rune M. Pedersen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
Ilies Benotmane et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
Alberto M. Borobia et al.
LANCET (2021)
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
Catherine M. Brown et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
SARS-CoV-2 variants of concern partially escape humoral but not T- cell responses in COVID-19 convalescent donors and vaccinees
Daryl Geers et al.
SCIENCE IMMUNOLOGY (2021)
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
Soumya Jaganathan et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Alison Tarke et al.
CELL REPORTS MEDICINE (2021)
After the pandemic: perspectives on the future trajectory of COVID-19
Amalio Telenti et al.
NATURE (2021)
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
Floriane Gallais et al.
EMERGING INFECTIOUS DISEASES (2021)
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
Isabella Quinti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
Annarosa Soresina et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
COVID-19 and the Path to Immunity
David S. Stephens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings
Francisco Javier Candel et al.
REVISTA ESPANOLA DE QUIMIOTERAPIA (2020)
An Effective COVID-19 Vaccine Needs to Engage T Cells
Karsten Sauer et al.
FRONTIERS IN IMMUNOLOGY (2020)
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
Gabriel N. Maine et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
Marc Hellerstein
VACCINE: X (2020)